Tumor genomic profiling can direct patients to new therapeutic possibilities. Positive responses aside, many patients are left with few treatment options. Download this presentation to learn how genomics can further illuminate the inherently complex tumor microenvironment – with beneficial implications for immuno-oncology strategies and the future of genomic testing for cancer treatment.

Author:
Victor Weigman, Ph.D., Director, Translational Genomics